Trilogy Capital Inc. Thermo Fisher Scientific Inc. Transaction History
Trilogy Capital Inc.
- $1.81 Billion
- Q2 2024
A detailed history of Trilogy Capital Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Trilogy Capital Inc. holds 1,548 shares of TMO stock, worth $957,484. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,548
Previous 502
208.37%
Holding current value
$957,484
Previous $291,000
194.16%
% of portfolio
0.05%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding TMO
# of Institutions
2,779Shares Held
340MCall Options Held
1.42MPut Options Held
2.15M-
Vanguard Group Inc Valley Forge, PA32.7MShares$20.2 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY29.5MShares$18.3 Billion0.38% of portfolio
-
State Street Corp Boston, MA16.2MShares$10 Billion0.4% of portfolio
-
Morgan Stanley New York, NY12.1MShares$7.48 Billion0.53% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.93MShares$6.14 Billion0.66% of portfolio
About THERMO FISHER SCIENTIFIC INC.
- Ticker TMO
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 391,788,992
- Market Cap $242B
- Description
- Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...